EPISODE · May 27, 2026 · 30 MIN
The real cost of PCR - beyond price per reaction
from Speaking of Mol Bio · host Steve Lewis, Cam Cyr
Not all experiments are created equal, and neither are the decisions behind them. In this episode, Cam Cyr explores how scientists navigate the balance between cost and performance in molecular biology workflows. Drawing from his experience as a technical sales specialist, Cam breaks down what “performance” really means in practice, from enzyme fidelity and sensitivity to reproducibility and inhibitor tolerance. He highlights how these factors become critical in high-stakes applications like antibody engineering or single-cell analysis, where errors can propagate and compromise entire workflows. Through examples like reverse transcription enzymes and high-fidelity polymerases, Cam illustrates why premium products are often essential when working with rare samples or build-critical steps. At the same time, he explains where cost-saving approaches make sense where results are binary and easy to replicate, such as genotyping or routine screening. Ultimately, the conversation reframes how scientists should think about cost, not as price per reaction, but as cost per successful result. Along the way, Cam shares his career journey from bench science to a customer-facing role, offering perspective on the many paths available in life sciences and the importance of staying curious. Suggested Links: View Thermo Fisher reverse transcription and PCR enzymes Learn more about Thermo Scientific™ EquiPhi29™ DNA Polymerase Explore careers at Thermo Fisher Scientific Subscribe to get future episodes as they drop and if you like what you’re hearing we hope you’ll share a review or recommend the series to a colleague. Visit the Invitrogen School of Molecular Biology to access helpful molecular biology resources and educational content, and please share this resource with anyone you know working in molecular biology. For Research Use Only. Not for use in diagnostic procedures.
What this episode covers
How do scientists balance cost, performance, and risk when choosing molecular biology tools? Cam Cyr shares real-world insights into how smarter reagent decisions can accelerate research and reduce costly experimental failures.
NOW PLAYING
The real cost of PCR - beyond price per reaction
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m